New Zealand markets closed
  • NZX 50

    12,497.10
    -115.21 (-0.91%)
     
  • NZD/USD

    0.6765
    -0.0019 (-0.28%)
     
  • ALL ORDS

    7,672.80
    +16.20 (+0.21%)
     
  • OIL

    87.09
    +0.13 (+0.15%)
     
  • GOLD

    1,840.10
    -3.10 (-0.17%)
     

10x Genomics Stock: Bull vs. Bear

·4-min read
10x Genomics Stock: Bull vs. Bear

Despite crushing the S&P 500 -- 180% to 63% -- since its September 2019 IPO, 10x Genomics' (NASDAQ: TXG) shares have only experienced 6% growth year to date. The company has rapidly become a cornerstone of biomedical research with its laboratory devices capable of profiling individual cells, but investors recently seem to have shrugged. Does the stock price just need a few quarters to catch up to its valuation?

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting